Market Overview:
The global percutaneous mechanical circulatory support devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of heart failure, technological advancements in percutaneous mechanical circulatory support devices, and rising demand for minimally invasive procedures. Based on type, the global percutaneous mechanical circulatory support devices market is segmented into extracorporeal membrane oxygenation device (ECMO), extracorporeal ventricular assist device (E-VAD), and others. The ECMO segment is expected to account for the largest share of the global percutaneous mechanical circulatory support devices market in 2018. This can be attributed to its ability to provide long-term oxygenation and ventilation assistance as well as hemodynamic stabilization for patients with severe heart failure or respiratory failure. Based on application, the global percutaneous mechanical circulatory support devices market is segmented into hospitals, specialized cardiac centers, ambulatory surgery centers, and others.
Product Definition:
Percutaneous mechanical circulatory support devices (PMCSDs) are devices used to help pump blood through the body. They may be used to provide short-term support for patients who are not able to pump blood on their own or as a permanent solution for patients with heart failure. PMCSDs can be inserted directly into the heart or used in conjunction with a ventricular assist device (VAD).
Extracorporeal Membrane Oxygenation Device:
Extracorporeal Membrane Oxygenation (ECMO) is a procedure wherein the body's natural respiratory process is used to provide supplementary oxygen to the patient. The ECMO device works by creating a connection between the patient's blood vessel and a machine that supplies oxygen which can be administered at any point of time during respiration.
Extracorporeal Ventricular Assist Device:
Extracorporeal ventricular assist device (ECVAD) is a machine that helps in pumping blood to the brain when the heart is unable to do so. ECVAD works by creating an artificial source of blood volume which can be attached to a patient’s own heart and lungs through a catheter. The extracorporeal portion of this device refers to its connection with the outside world via a membrane oxygenator or an artificial lung.
Application Insights:
Based on application, the global market is segmented into hospitals, specialized cardiac centers, ambulatory surgery centers and others. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities along with a large patient base. Moreover, these centers offer better treatment options than other medical facilities and are equipped with highly sophisticated devices that aid in efficient delivery of oxygenated blood flow to organs thereby improving the overall health condition of patients suffering from respiratory failure or anoxic brain injury.
Specialized cardiac center is expected to be fastest growing segment over forecast period due to increasing number of percutaneous mechanical circulatory support devices procedures being performed at regular intervals at these centers across the globe for various conditions such as severe heart failure or cardiogenic shock resulting in inadequate perfusion pressure provided by conventional methods thus driving growth rate higher.
Regional Analysis:
North America dominated the global percutaneous mechanical circulatory support devices market in 2017. This can be attributed to favorable reimbursement policies, increasing prevalence of cardiac disorders, and rising awareness about these machines. Moreover, the presence of major players in this region is expected to drive growth during the forecast period. The U.S., which accounted for a majority share in North America market owing to high demand for ECMO and PVASC devices is expected witness significant growth over the forecast period due to an increase in cases of heart failure & cardiac arrest as well as other cardiovascular diseases (CVDs).
Asia Pacific is anticipated to grow at a lucrative rate during the forecast period owing to factors such as improving healthcare infrastructure & availability of advanced therapies resulting into better patient care experience facilitating adoption by patients and physicians alike thereby driving demand for PMCI devices over next six years.
Growth Factors:
- Increasing incidence of heart failure: The global incidence of heart failure is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits, which are leading to an increase in the number of people suffering from obesity and other cardiovascular diseases. This is providing a major boost to the demand for percutaneous mechanical circulatory support devices as they offer an effective treatment option for patients with advanced heart failure.
- Technological advancements: The percutaneous mechanical circulatory support devices market is witnessing rapid technological advancements, with manufacturers introducing new products that are more efficient and easier to use. This is helping to expand the reach of these devices to a wider population base and driving growth in the market.
- Growing awareness about advanced therapies: There has been a growing awareness among patients and healthcare professionals about the benefits offered by advanced therapies such as percutaneous mechanical circulatory support devices therapy for treating heart failure patients who are not responding well to traditional treatments options such as medication or surgery .This is helping fuel growth in this market segment .
Scope Of The Report
Report Attributes
Report Details
Report Title
Percutaneous Mechanical Circulatory Support Devices Market Research Report
By Type
Extracorporeal Membrane Oxygenation Device, Extracorporeal Ventricular Assist Device, Others
By Application
Hospitals, Specialized Cardiac Centers, Ambulatory Surgery centers, Others
By Companies
Medtronic, Abbott Laboratories, LivaNova, Eurosets, Jarvik Heart, Cardiobridge, Getinge AB, ABIOMED, Teleflex Incorporated, Berlin Heart
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Percutaneous Mechanical Circulatory Support Devices Market Report Segments:
The global Percutaneous Mechanical Circulatory Support Devices market is segmented on the basis of:
Types
Extracorporeal Membrane Oxygenation Device, Extracorporeal Ventricular Assist Device, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialized Cardiac Centers, Ambulatory Surgery centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Abbott Laboratories
- LivaNova
- Eurosets
- Jarvik Heart
- Cardiobridge
- Getinge AB
- ABIOMED
- Teleflex Incorporated
- Berlin Heart
Highlights of The Percutaneous Mechanical Circulatory Support Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Extracorporeal Membrane Oxygenation Device
- Extracorporeal Ventricular Assist Device
- Others
- By Application:
- Hospitals
- Specialized Cardiac Centers
- Ambulatory Surgery centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Percutaneous Mechanical Circulatory Support Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A percutaneous mechanical circulatory support devices (PMCSD) is a medical device that helps to improve blood flow and oxygen delivery to the body. PMCSDs are inserted into the body through a small incision, and can be used in cases of heart failure, stroke, or other conditions that cause decreased blood flow.
Some of the major companies in the percutaneous mechanical circulatory support devices market are Medtronic, Abbott Laboratories, LivaNova, Eurosets, Jarvik Heart, Cardiobridge, Getinge AB, ABIOMED, Teleflex Incorporated, Berlin Heart.
The percutaneous mechanical circulatory support devices market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Percutaneous Mechanical Circulatory Support Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Percutaneous Mechanical Circulatory Support Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Percutaneous Mechanical Circulatory Support Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Percutaneous Mechanical Circulatory Support Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Percutaneous Mechanical Circulatory Support Devices Market Size & Forecast, 2018-2028
4.5.1 Percutaneous Mechanical Circulatory Support Devices Market Size and Y-o-Y Growth
4.5.2 Percutaneous Mechanical Circulatory Support Devices Market Absolute $ Opportunity
Chapter 5 Global Percutaneous Mechanical Circulatory Support Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Type
5.2.1 Extracorporeal Membrane Oxygenation Device
5.2.2 Extracorporeal Ventricular Assist Device
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Percutaneous Mechanical Circulatory Support Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialized Cardiac Centers
6.2.3 Ambulatory Surgery centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Percutaneous Mechanical Circulatory Support Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Percutaneous Mechanical Circulatory Support Devices Analysis and Forecast
9.1 Introduction
9.2 North America Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Type
9.6.1 Extracorporeal Membrane Oxygenation Device
9.6.2 Extracorporeal Ventricular Assist Device
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialized Cardiac Centers
9.10.3 Ambulatory Surgery centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Percutaneous Mechanical Circulatory Support Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Type
10.6.1 Extracorporeal Membrane Oxygenation Device
10.6.2 Extracorporeal Ventricular Assist Device
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialized Cardiac Centers
10.10.3 Ambulatory Surgery centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Percutaneous Mechanical Circulatory Support Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Type
11.6.1 Extracorporeal Membrane Oxygenation Device
11.6.2 Extracorporeal Ventricular Assist Device
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialized Cardiac Centers
11.10.3 Ambulatory Surgery centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Percutaneous Mechanical Circulatory Support Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Type
12.6.1 Extracorporeal Membrane Oxygenation Device
12.6.2 Extracorporeal Ventricular Assist Device
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialized Cardiac Centers
12.10.3 Ambulatory Surgery centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Percutaneous Mechanical Circulatory Support Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Type
13.6.1 Extracorporeal Membrane Oxygenation Device
13.6.2 Extracorporeal Ventricular Assist Device
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Percutaneous Mechanical Circulatory Support Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialized Cardiac Centers
13.10.3 Ambulatory Surgery centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Percutaneous Mechanical Circulatory Support Devices Market: Competitive Dashboard
14.2 Global Percutaneous Mechanical Circulatory Support Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Abbott Laboratories
14.3.3 LivaNova
14.3.4 Eurosets
14.3.5 Jarvik Heart
14.3.6 Cardiobridge
14.3.7 Getinge AB
14.3.8 ABIOMED
14.3.9 Teleflex Incorporated
14.3.10 Berlin Heart
